Enovis Corp
NYSE:ENOV

Watchlist Manager
Enovis Corp Logo
Enovis Corp
NYSE:ENOV
Watchlist
Price: 44.28 USD 0.75%
Market Cap: 2.5B USD
Have any thoughts about
Enovis Corp?
Write Note

Enovis Corp
Minority Interest

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Enovis Corp
Minority Interest Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Minority Interest CAGR 3Y CAGR 5Y CAGR 10Y
Enovis Corp
NYSE:ENOV
Minority Interest
$2.3m
CAGR 3-Years
-63%
CAGR 5-Years
-59%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Minority Interest
$248m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Minority Interest
$232m
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Minority Interest
$94.2m
CAGR 3-Years
24%
CAGR 5-Years
43%
CAGR 10-Years
N/A
No Stocks Found

Enovis Corp
Glance View

Market Cap
2.5B USD
Industry
Health Care

Enovis Corp., a company with a steadfast commitment to innovation and growth, operates within the specialized world of medical technology. Originally a part of Colfax Corporation, it underwent a strategic transformation, branching out into its own entity, laser-focused on advancing human mobility through cutting-edge orthopedic solutions. Enovis has carved its niche by developing and manufacturing high-quality, bespoke orthopedic products that serve both surgical and non-surgical needs. These offerings are designed to enhance patient recovery and mobility, thereby improving quality of life. Its extensive product portfolio includes surgical implants, bracing, rehabilitation solutions, and intelligent digital care platforms, positioning Enovis at the intersection of healthcare and technology. Revenue for Enovis streams from its diverse array of products and solutions targeted at healthcare professionals and institutions worldwide. The company thrives by engaging in both direct sales and a network of distributors to ensure its innovative solutions reach a broad spectrum of the healthcare landscape. By continually investing in research and development, Enovis maintains its competitive edge, launching new products that address evolving medical needs. This proactive approach not only caters to the existing demand but also stimulates new markets by educating and training medical professionals and leading them through transformative, evidence-based clinical outcomes. In essence, Enovis Corp. excels by integrating science and technology to fuel both financial growth and human betterment.

ENOV Intrinsic Value
71.19 USD
Undervaluation 38%
Intrinsic Value
Price

See Also

What is Enovis Corp's Minority Interest?
Minority Interest
2.3m USD

Based on the financial report for Dec 31, 2023, Enovis Corp's Minority Interest amounts to 2.3m USD.

What is Enovis Corp's Minority Interest growth rate?
Minority Interest CAGR 5Y
-59%

Over the last year, the Minority Interest growth was 35%. The average annual Minority Interest growth rates for Enovis Corp have been -63% over the past three years , -59% over the past five years .

Back to Top